伯乐生命医学-B BIO.B
$379.50 +$0.00 (0.00%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $379.50 0.00%
开盘$0.00
昨收$379.50
当日区间$0.00 – $0.00
成交量9.00
市值$10.21B
市盈率（TTM）10.1
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例88.1%-0.44 个百分点，较上季度
持仓机构数481+4 ，较上季度
内部人近期交易32次买入 / 18次卖出净买入
空头持仓比例0.00% 占流通股回补天数 1.0 · 截至 30 Sep 2026
卖空成交量占比0.0%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$58.4K（0个净流入日，20个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有39.4%的流通股。
最大股东
按投资者类型
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +24,013 | 0.1% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +112,244 | 0.5% |
| Nomura Holdings, Inc. | Public Company | 2026/Q3 | +111,555 | 1.2% |
| Neuberger Berman Investment Advisers LLC | Mutual Fund | 2026/Q3 | +108,802 | 0.4% |
| SG Americas Securities, LLC | Private Company | 2026/Q3 | +103,817 | 0.6% |
| Victory Capital Management Inc. | Mutual Fund | 2026/Q3 | +103,487 | 0.5% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +98,209 | 0.7% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +92,687 | 0.4% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +85,393 | 0.9% |
| Wells Fargo & Company | Public Company | 2026/Q3 | +76,810 | 0.4% |
| Capital Research | Mutual Fund | 2026/Q3 | +70,361 | 3.4% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +60,249 | 0.2% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +56,601 | 0.2% |
| Bank of America Corporation | Public Company | 2026/Q3 | +50,670 | 0.4% |
| The Bank of Nova Scotia | Public Company | 2026/Q3 | +39,708 | 0.1% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | Jonathan DiVincenzo | President | Derivative Exercise and Sale | -951 | $369.95 | 2,881 |
| 23 Oct 2026 | Jonathan DiVincenzo | President | Derivative Exercise and Retained | +918 | – | 2,881 |
| 19 Oct 2026 | Sedat Evran | Executive Vice President of Global Supply Chain | Derivative Exercise and Sale | -487 | $354.50 | 4,160 |
| 19 Oct 2026 | Sedat Evran | Executive Vice President of Global Supply Chain | Derivative Exercise and Retained | +557 | – | 4,160 |
| 5 Sep 2026 | Norman Schwartz | Chairperson & CEO | Derivative Exercise and Sale | -4,730 | $386.11 | 812,663 |
| 5 Sep 2026 | Norman Schwartz | Chairperson & CEO | Derivative Exercise and Retained | +2,834 | – | 812,663 |
| 5 Sep 2026 | Roop Lakkaraju | Chief Financial Officer | Derivative Exercise and Sale | -1,341 | $386.11 | 4,151 |
| 5 Sep 2026 | Roop Lakkaraju | Chief Financial Officer | Derivative Exercise and Retained | +1,565 | – | 4,151 |
| 5 Sep 2026 | Eva Engelhardt | Executive VP & President of the Clinical Diagnostics Group | Derivative Exercise and Sale | -854 | $386.11 | 1,828 |
| 5 Sep 2026 | Eva Engelhardt | Executive VP & President of the Clinical Diagnostics Group | Derivative Exercise and Retained | +1,325 | – | 1,828 |
| 5 Sep 2026 | Allison Schwartz | Director | Derivative Exercise and Sale | -116 | $386.11 | 1,734 |
| 5 Sep 2026 | Allison Schwartz | Director | Derivative Exercise and Retained | +204 | – | 1,734 |
| 5 Sep 2026 | James Barry | Executive VP & President of Life Science Group | Derivative Exercise and Sale | -839 | $386.11 | 2,025 |
| 5 Sep 2026 | James Barry | Executive VP & President of Life Science Group | Derivative Exercise and Retained | +1,244 | – | 2,025 |
| 5 Sep 2026 | Sedat Evran | Executive Vice President of Global Supply Chain | Derivative Exercise and Sale | -606 | $386.11 | 3,603 |
| 5 Sep 2026 | Sedat Evran | Executive Vice President of Global Supply Chain | Derivative Exercise and Retained | +1,285 | – | 3,603 |
| 5 Sep 2026 | Courtney Enloe | General Counsel | Derivative Exercise and Sale | -551 | $386.11 | 1,652 |
| 5 Sep 2026 | Courtney Enloe | General Counsel | Derivative Exercise and Retained | +902 | – | 1,652 |
| 4 Sep 2026 | Jonathan DiVincenzo | President | Derivative Exercise and Sale | -668 | $386.11 | 1,963 |
| 4 Sep 2026 | Jonathan DiVincenzo | President | Derivative Exercise and Retained | +1,044 | – | 1,963 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 30 Sep 2026 | 1 | 0.0% | 1.0 |
| 14 Aug 2026 | 2 | 0.0% | 1.0 |
| 31 Jul 2026 | 2 | 0.0% | 1.0 |
| 15 Jul 2026 | 31 | 0.0% | 1.0 |
| 30 Jun 2026 | 220 | 0.0% | 2.1 |
| 15 Jun 2026 | 1 | 0.0% | 1.0 |
暂无评论——快来第一个聊聊 BIO.B。
登录后参与讨论。